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Background: The rate of central line-associated bloodstream infection (CLABSI) in 
South African public sector neonatal intensive care units (NICU) is unknown. Tygerberg 
Children’s Hospital (TCH) introduced a neonatal CLABSI surveillance and prevention 
programme in August 2012. 
Objectives: To describe CLABSI events and identify risk factors for development of 
CLABSI in a resource-limited NICU.  
Methods: A retrospective case-control study was conducted using prospectively 
collected NICU CLABSI events matched to four randomly selected controls, sampled 
from the NICU registry between 9 August 2012 and 31 July 2014. Clinical data and 
laboratory records were reviewed to identify possible risk factors using stepwise forward 
logistic regression analysis.  
Results: Seven hundred and six central lines were inserted in 530 neonates during the 
first two years of the programme. Nineteen CLABSI events were identified with a 
CLABSI rate of 5.9/1000 line days. CLABSI cases were of lower gestational age (28 vs 
34 weeks; p=0.003), lower median birth weight (1170g vs 1975g; p=0.014), had longer 
catheter dwell times (> 4 days) (OR 5.1 [95% CI 1.0-25.4]; p=0.04) and were more likely 
to have surgery during their NICU stay (OR 3.5 [95% CI 1.26-10]; p=0.01). Significant 
risk factors for CLABSI were length of stay > 30 days (OR 20.7 [95% CI 2.1-203.2]; 
p=0.009) and central line insertion in the operating theatre (OR 8.1; [95% CI 1.2-54.7]; 
p=0.03). Gram-negative pathogens predominated (12/22; 54%), with most isolates 10/12 
(83%) exhibiting multi-drug resistance. 
Conclusion: The TCH NICU CLABSI rate is similar to that reported from resource-
limited settings but far exceeds that of high-income countries. Prolonged NICU stay and 
central line insertion in the operating theatre were important risk factors for CLABSI 
development. Intensified neonatal staff training regarding CLABSI maintenance bundle 
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CLABSI = Central line-associated bloodstream infection  
NICU = Neonatal intensive care unit 
TCH = Tygerberg Children’s Hospital 
HAI = Healthcare-associated infections 
LMIC = Low-middle income countries  
ICU = Intensive care unit 
TPN = Total parenteral nutrition 
INICC = International Nosocomial Infection Control Consortium  
NHSN = National Healthcare Safety Network 
CDC = Centres for Disease Control and Prevention 
UVC = Umbilical venous catheter 
PICC = Peripherally inserted central catheter 
CVC = Central venous catheter 
LC-BSI = Laboratory confirmed bloodstream infection  
HIV = Human Immunodeficiency Virus 
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Introduction 
In most low-resource settings, surveillance of healthcare-associated infection (HAI) is 
limited or non-existent. A meta-analysis of HAI in low-middle income countries (LMIC) 
reported infection rates double that of developed countries, and a tripling of HAI rates in 
intensive care units (ICU).(1) Central line-associated bloodstream infections (CLABSI) 
are a type of device-associated HAI mainly encountered in the ICU setting, resulting in 
longer hospital stay and higher costs.(2-3) Data on CLABSI rates in LMIC is scant, 
particularly from NICU settings. 
 
The use of central lines in NICU is often unavoidable with lines used for administration 
of intravenous fluids, blood products, inotropes, antibiotics and total parenteral nutrition 
(TPN). Even without the use of invasive devices, hospitalized neonates are at increased 
risk of infection owing to prematurity, poor skin integrity and prolonged 
hospitalisation.(4) Resource-limited countries contributing data to the International 
Nosocomial Infection Control Consortium (INICC) (3,5) report NICU CLABSI rates 3 to 
4-fold higher than those documented by the United States National Health Surveillance 
System (NHSN).(6-7) 
 
In high-income country NICU’s, CLABSI rates declined dramatically following 
widespread implementation of central line bundles.(8-10) A CLABSI bundle is a strategy 
for insertion and maintenance of central lines, which includes several evidence-based best 
practices implemented simultaneously.(11-12) Central line care bundle elements include: 
hand hygiene, optimal catheter site selection, maximal barrier precautions at insertion, 
chlorhexidine skin antisepsis, daily review of line necessity, sterile line access, use of 
closed needleless intravascular catheter systems and ensuring the line dressing stays clean 
and intact.(11-12)  
 
Reductions in NICU CLABSI rates have been achieved in developing countries (13-14), 
but data from African NICU’s is extremely limited.(5,15) Our study reports the first 
CLABSI surveillance programme data from a public sector NICU in South Africa and 
aims to identify risk factors for CLABSI in this setting. 
 
Methods 
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Study setting   
Tygerberg Hospital is a public sector teaching hospital in Cape Town, South Africa. The 
neonatal service provides care to both inborn babies and neonates referred in from 
surrounding clinics and hospitals. Approximately 7800 babies were born per year in 2012 
and 2013: 40% were low birth weight (<2500g), 13% were very low birth weight 
(<1500g) and 6% were extremely low birth weight (<1000g) infants.(16) The neonatal 
service includes the NICU with 8 intensive care beds and 4 high-care beds, as well as 112 
ward beds. In the year 2013 the NICU had 491 admissions and the wards 5265.(16) 
 
Indications for central line insertion in the NICU include requirement for TPN and/or 
inotropes, as well as neonates who require intravenous fluids and/or antibiotics where 
peripheral intravenous access is not possible or difficult to obtain. Umbilical venous 
catheters (UVC’s) and peripherally inserted central catheters (PICC’s) are first and 
second choice central lines and are inserted by paediatric registrars or medical officers. 
Central venous catheters (CVC’s) and broviac lines are inserted in patients who have 
difficult intravenous access or where attempts at other central lines have failed and/or in 
post-surgical patients who need TPN. Broviac lines are inserted by the paediatric surgical 
team and CVC’s are inserted by either the paediatric surgery or anaesthetic team.  
 
The TCH NICU CLABSI surveillance and prevention program was implemented on 9 
August 2012 with the aims of determining baseline CLABSI rates through prospective 
surveillance and reducing CLABSI events through use of central line insertion and 
maintenance bundles.  
 
Study design   
The prospectively compiled NICU central line register was used to identify cases and 
controls. All cases within the two year study period (9 August 2012 - 31 July 2014) were 
included, with 4 randomly selected controls per CLABSI event. Research randomizer (a 
computer programme that generates random numbers) (17) was used to select 4 controls 
for each CLABSI case, matching only for the year of the programme i.e. 9 August 2012 - 
31 July 2013 or 1 August 2013 - 31 July 2014.  
 
Hospital and laboratory records for the cases and controls were retrospectively reviewed. 
If a “control” folder was not available or the information in the folder was incomplete, 
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the next randomly selected folder number was used. Information obtained from the 
folders for both cases and controls included: patient demographics, details of their NICU 
stay and central line information. Additional information was obtained for all CLABSI 
cases: weight closest to CLABSI event onset, number of CLABSI’s per patient, date of 
CLABSI event, pathogen isolated and antibiotic susceptibility; antibiotics used prior to 
and after CLABSI diagnosis; white cell count, platelet count, haemoglobin and C-
reactive protein result 48-72 hours prior to CLABSI and 24-48 hours after CLABSI. 
 
All positive cultures from catheter tips submitted from the NICU during the study period 
and all blood culture results of babies who died or were transferred to other neonatal 
wards with central lines in situ were evaluated for possible missed CLABSI cases. 
Umbilical arterial lines were excluded from this study because surveillance of these lines 
was not part of the programme initially and none of the CLABSI cases were attributed to 
arterial lines. The CLABSI register was the primary data source used to determine total 
patients and central line days in order to calculate the CLABSI rate. 
 
Definitions 
The US Centres for Disease Control and Prevention (CDC)/NHSN 2014 definitions for 
HAI were used.(18) CLABSI is defined as a laboratory confirmed bloodstream infection 
(LC-BSI) in a patient with a central line in situ for at least two calendar days (where line 
insertion is day 1). It is still considered a CLABSI if a LC-BSI occurred within one day 
of line removal. The definition for HAI and LC-BSI must be met before the definition of 
CLABSI can be applied and other HAI must be excluded. The CLABSI rate per 1000 
central line days is calculated by dividing the number of CLABSI by the number of 
central line days and multiplying the result by 1000. Line days are the total number of 
days of exposure to central venous catheters by all patients in the selected population and 
time period. Definitions of multidrug-resistance applied from Magiorakos et al (19) were 
used to report on the antibiotic-susceptibility profile of pathogens. Mangram et al’s (20) 




Normally distributed data was described using means and standard deviations; non-
parametric data was described with medians and interquartile ranges. The Chi-square test 
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was used to compare demographics of CLABSI cases vs controls; a p-value <0.05 was 
considered statistically significant. Stepwise forward logistic regression analysis was 




Approval of the study (including a waiver of individual informed consent) was obtained 




Fourteen CLABSI episodes were documented in the CLABSI register. One CLABSI 
episode was excluded from the study because it did not meet the CLABSI definition as 
per CDC/NHSN 2014 guidelines. An additional six “missed” CLABSI episodes were 
added following review of laboratory and hospital records, yielding a total of 19 CLABSI 
events for which 76 controls were selected (a total of 95 study patients). The NICU 
CLABSI surveillance registers documented insertion of 706 central lines into 530 
neonates during the first two years of the programme (a total of 3187 central line days). 
Nineteen CLABSI episodes in 17 patients were identified, yielding a CLABSI rate of 
5.9/1000 line days. The demographics of the study population are summarised in Table 1. 
 
Nine of the CLABSI cases had medical indications for admission: hyaline membrane 
disease (3), meconium aspiration syndrome (2), presumed nosocomial sepsis (2), 
congenital cytomegalovirus infection (1) and pulmonary haemorrhage (1). Eight patients 
that had undergone abdominal surgery during their current or previous NICU admission 
developed CLABSI episodes (10/19; 53%); including one surgical baby admitted to 
NICU for 107 days who experienced three CLABSI events with different pathogens on 
three separate lines. Of the eight babies who underwent surgery, five had a wound class 
of III/ IV (contaminated or dirty) (20). Comparison of septic markers 48 hours prior to 
and at/within 24 hours after the CLABSI event confirmed the possibility of sepsis with a 
decrease in white cell count, platelets and/or raised C-reactive protein. Of the five 
neonates who demised (26.3%), three deaths were directly attributed to the CLABSI 
event, one to necrotizing enterocolitis and one to congenital abnormalities. The babies 
that died from CLABSI were of very low birth weight (<1500g), premature, had medical 
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indications for NICU admission and died within 48 hours of CLABSI diagnosis. The 
catheter dwell times in NICU and time to CLABSI onset after insertion of different 
central line types are summarised in Table 2. 
 
Of the 19 CLABSI events, 16 were mono-microbial and 3 were poly-microbial with 2 
pathogens each (a total of 22 laboratory-confirmed pathogens). Gram-negative organisms 
predominated (12/22; 54%) followed by Gram-positives (5/22; 23%) and fungi (5/22; 
23%). Antimicrobial susceptibility testing was performed on all isolates. Gram-negatives 
exhibited high rates of antimicrobial resistance: 6/7 A. baumannii were multidrug-
resistant and 4/5 K. pneumoniae produced extended-spectrum beta-lactamases (Table 2). 
Fungi isolated were Candida albicans (3), Candida parapsilosis (1) (all fluconazole 
susceptible) and Candida krusei (1) susceptible to amphotericin B and voriconazole. For 
14/19 CLABSI events, patients were receiving antibiotics for other indications prior to 
the development of CLABSI. A change in the antimicrobial treatment was made in 16/19 
(84%) patients who showed clinical deterioration or had a change in their septic markers, 
while awaiting blood culture results. After results of antimicrobial susceptibility testing 
were available: 9 patients required a change in treatment, 4 had therapy targeted to the 
pathogen isolated, 1 had an antimicrobial agent added, 1 remained on broad-spectrum 
antibiotics for suspected Gram-negative sepsis, another had incomplete notes. Three 
babies died before susceptibility testing results were available. 
 
Two-thirds of the cohort were premature with a lower median gestational age and birth 
weight among the cases (28 vs 34 weeks; p=0.003 and 1170g vs 1975g; p=0.014). The 
median length of stay in NICU was 7 days but significantly longer in neonates who 
developed CLABSI (26 vs 5 days; p=<0.001). Both groups had a greater proportion of 
male infants. Human immunodeficiency virus (HIV) exposure rates were similar between 
cases and controls; of the five HIV-exposed neonates who developed CLABSI, all tested 
HIV polymerase chain reaction (PCR) negative within the first two weeks of life. Seven 
controls were HIV-exposed, but had an unknown HIV-PCR result. The predominant line 
types used were UVC’s (58%) and PICC’s (24%). Broviac lines (3%) and CVC’s (15%) 
were less frequently used, and almost exclusively inserted in the operating theatre (all 3 
Broviac lines and 3/4 CVC’s).  Infection rates of lines inserted in NICU were 
significantly lower than that of lines inserted in the operating theatre (12/78 [15%] vs 
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7/15[41%]; p=0.012). Only 3 Broviac lines were inserted over the 2-year study period 
and all 3 developed CLABSI. 
  
Table 3 lists the factors associated with the development of CLABSI. In the stepwise 
forward logistic analysis, significant risk factors included insertion of central line in the 
operating theatre (OR 8.1; [95% CI 1.2-54.7]; p=0.03) and length of NICU stay > 30 days 
(OR 20.7 [95% CI 2.1-203.2]; p=0.009). 
 
Discussion 
The CLABSI rate of 5.9/1000 lines in our NICU is similar to that reported from other 
LMIC but much higher than CLABSI rates in high-income settings. Limited resources, 
understaffing, overcrowding and the high rate of premature and low birth weight babies 
probably contributed to our high CLABSI rate. In this setting, CLABSI cases occurred 
more commonly in babies of lower gestational age, lower birth weight, those undergoing 
surgical procedures and patients with catheter dwell time exceeding 4 days. 
 
A patient with a central line, who was admitted to NICU for longer than 30 consecutive 
days, was 20 times more likely to develop a CLABSI event, than patients with shorter 
NICU stays. This result remained significant in multivariate analysis, although the 
confidence interval was very wide. The wide confidence level can be attributed to the 
small number of cases. We postulate that the increased risk associated with CLABSI and 
long NICU stay may be due to increased risk of bacterial colonisation in critically-ill 
patients with complicated and/or multi-system disease (21,22).  
 
In our setting, central lines inserted in the operating theatre (Broviac and CVC’s) had an 
8-fold increased risk of CLABSI compared with lines inserted in NICU. The increased 
risk could arise during the insertion and/or the maintenance of these lines. CLABSI 
events related to insertion factors usually develop within 48-72 hours of line insertion, 
suggesting that line maintenance issues were more likely responsible for Broviac and 
CVC CLABSI’s (median time to infection onset of 20 and 7 days respectively). Insertion 
of Broviac’s and CVC’s are also technically more difficult and often inserted in patients 
with difficult venous access, or where attempts at inserting other central line types have 
failed. In addition, these lines were more likely to be used for TPN, possibly contributing 
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to infection risk. Another notable difference is that central line insertion checklists are 
routinely completed for lines inserted in NICU, but not for lines inserted in theatre. In 
light of these findings, the insertion bundle checklist should be implemented in theatre 
and education of all staff involved in maintenance of surgically inserted lines (not only 
NICU staff) undertaken. Central lines increase the risk of bloodstream infection (21,23) 
and known risk factors for CLABSI include administration of TPN (21-23,25), frequent 
manipulation of the line (26), open vascular systems (27,28), not using needleless 
connections (12) and the use of multiple access ports.(12) Conflicting data exist on which 
type of central line is associated with the highest risk for CLABSI.(23,29,30). Prolonged 
catheter dwell time is confirmed to increase infection risk in UVC’s (31), conflicting data 
exist for PICC’s (29,30,32) and data in Broviac lines and CVC’s in neonates are lacking. 
 
In our study nearly 80% of neonates who experienced CLABSI events were premature 
and half required surgery. Although surgery during NICU stay and catheter dwell time in 
NICU was not significant in the multivariate analysis, an association was found in the 
univariate analysis. The limited data available for neonates undergoing surgery suggest 
that premature infants, those with stomas and patients with multiple surgical interventions 
are at highest risk of developing a CLABSI.(33) Coffin et al developed a definition for 
CLABSI in neonates with presumed mucosal barrier injury due to gastrointestinal 
conditions (including abdominal surgery) noting that this group were at increased risk of 
recurrent CLABSI.(34)  
 
Our study did not confirm TPN administration as a significant risk factor for CLABSI but 
we were unable to compare the duration of TPN administration in the cases versus 
controls. Surgery during NICU, catheter dwell time and prolonged stay in NICU could all 
be risk factors related to a specific group of patients requiring long-term TPN. Future 
research is required to evaluate these factors and the cost effectiveness of establishing a 
TPN unit for babies who are infection free but require long-term central lines for TPN. 
 
The pathogens isolated were predominantly antibiotic-resistant Gram-negatives, in 
keeping with findings of a prior study of bloodstream infections in TCH NICU by Morkel 
et al.(35) The high rate of antimicrobial-resistance highlights the importance of our 
CLABSI surveillance and prevention programme and the need for continued antibiotic 
stewardship. 
Stellenbosch University  https://scholar.sun.ac.za
 14 
  
Study limitations included: a small number of cases making it difficult to extrapolate 
findings to the larger population, an unknown baseline CLABSI rate prior to 
implementing the CLABSI programme and the retrospective collection of clinical data 
for the controls. This study did not specifically evaluate adherence to specific 
maintenance bundle elements (including number of access ports, use of needless 
connectors and accessing central lines in a sterile manner). Other important CLABSI 
prevention strategies not explored in this study include daily assessment of the need for a 
central line, prevention of prematurity and promotion of early enteral feeding. Although 
the NICU had established a CLABSI registry, we identified 6 missed CLABSI events, 
suggesting a need for improved surveillance methods.  
 
Despite these limitations, this study is (to our knowledge) the first study to establish 
CLABSI rates and risk factors in a South African public sector NICU. The establishment 
of a baseline CLABSI rate has assisted us with setting targets for the programme, 
assessing the impact of interventions and benchmarking ourselves against other similar 
NICU’s. LMIC are faced with unique challenges such as staff shortages, high patient 
turnover and limited resources, making prevention of HAI’s like CLABSI very difficult. 
Support from management and ongoing in-service training of all staff involved in the 
insertion and maintenance of central lines in neonates is vital to sustain and improve our 
CLABSI prevention and surveillance programme. Other resource-limited NICU’s can 
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Table 1: Characteristics of the study population (n=95) 
 
Variable assessed Number (%) 




















Gestational age  
































* Catheter dwell time in NICU 
 
< 4 days 
4-8 Days 






















61 (64) 13 (68) 48 (63) 0.669 
HIV-exposed 
 
21 (22) 5 (26) 16 (21) 0.621 




























     

























Respiratory support in NICU 86 (91) 18 (95) 68 (89) 0.480 
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Inotropes in NICU 
 
43 (45) 11 (58) 32 (42) 0.216 
TPN via central line 
 
72 (76) 16 (84) 56 (74) 0.338 
Surgery during NICU stay 
 
28 (29) 10 (53) 18 (24) 0.013 
Final outcome (survived) 
 
75 (79) 14 (74) 61 (80) 0.529 
CLABSI = central line-associated bloodstream infection; n = number; SD = standard deviation; IQR = 
interquartile range; NICU = neonatal intensive care unit; LOS = length of stay; UVC = umbilical venous 
catheter; PICC = peripherally inserted central catheter; CVC = central venous catheter; TPN = total 
parenteral nutrition. *For cells with <5 observations the Fishers exact test was used; for cells with >5 
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Table 2: Characteristics of CLABSI episodes (n=19) 
Total number of cases*, n 19 












Weight closest to CLABSI (gram), median (IQR) 1400 
(1029-2510) 
Catheter dwell time in NICU, median (IQR) 











Pathogens causing CLABSI (n = 22) 
 
Gram-positive organisms (Total), n (%) 
Staphylococcus aureus 
Coagulase negative Staphylococci 
             Enterococcus faecalis 
 























CLABSI = central line-associated bloodstream infection; n = number; IQR = interquartile range; UVC = 
umbilical venous catheter; PICC = peripherally inserted central catheter; CVC = central venous catheter  
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Table 3: Risk factors for CLABSI 
Variable Unadjusted Analysis Adjusted Analysis 
OR 95%CI p-value OR 95%CI p-value 
Length of stay 
< 7 days (reference) 
 7-29 days 

































Catheter dwell time 










Surgery during NICU stay 
 Any surgery performed 3.5 1.26-10 0.01 
Birth weight 














CLABSI = central line-associated bloodstream infection; NICU = neonatal intensive care unit; OR = odds 
ratio; 95%CI = 95% Confidence interval 
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